[Federal Register Volume 66, Number 219 (Tuesday, November 13, 2001)]
[Notices]
[Page 56839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-28311]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Secretary's Advisory Committee on Xenotransplantation.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4), Title 5 U.S.C., as amended 
because disclosure of such information is likely to disclose privileged 
or confidential trade secrets and commercial information.

    Name of Committee: Secretary's Advisory Committee on 
Xenotransplantation.
    Date: November 29-30, 2001.
    Open: November 29, 2001; 8:30 a.m. to 5:30 p.m.
    Agenda: Presentations and discussion of the development of a 
national xenotransplantation database and biological archive and 
updates on recent meetings and scientific advances in 
xenotransplantation. Time will be allotted to concurrent breakout 
sessions and plenary progress reports of the SACX Working Groups on 
informed consent issues and on the state of the science of 
xenotransplantation. There will also be opportunity for public 
commentary.
    Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, 
MD 21044.

    Open: November 30, 2001, 8:30 a.m. to 10:30 a.m.
    Agenda: Overviews of clinical xenotransplantation trials and 
retroviral screening practices and findings, and background on 
xenotransplantation products that involve ex vivo contact with well 
characterized cell lines.
    Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, 
MD 21044.

    Closed: November 30, 2001, 10:30 a.m. to 2 p.m.
    Agenda: Committee will be briefed by the Food and Drug 
Administration on specific confidential information concerning 
clinical trials in the area of xenotransplantation.
    Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia, 
MD 21044.
    Contact Person: Mary Groesch, Ph.D., Executive Director, 
Secretary's Advisory Committee on Xenotransplantation, Office of 
Science Policy, Rockledge I, Room 750, Bethesda, MD 20892, 301-496-
9838.

    Information is also available on the Office's home page: 
www4.od.nih.gov/oba/xenomtg.htm, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.187, Undergraduate 
Scholarship Program for Individuals from Disadvantaged Backgrounds; 
93.22, Clinical Research Loan Repayment Program for Individuals from 
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for 
Research Generally; 93.39, Academic Research Enhancement Award; 
93.936, NIH Acquired Immunodeficiency Syndrome Research Loan 
Repayment Program, National Institutes of Health, HHS)

    Dated: November 1, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-28311 Filed 11-9-01; 8:45 am]
BILLING CODE 4140-01-M